Valuation: Lifecare ASA

Market Cap 12Cr 1.28Cr 1.1Cr 1.03Cr 93.83L 1.77Cr 122.57Cr 1.79Cr 12Cr 4.72Cr 62Cr 4.81Cr 4.7Cr 203.64Cr P/E 2026 *
-0.83x
P/E 2027 * -1.83x
Enterprise Value 11Cr 1.18Cr 1.01Cr 94.87L 86.74L 1.64Cr 113.31Cr 1.65Cr 11Cr 4.37Cr 57Cr 4.44Cr 4.35Cr 188.25Cr EV / Sales 2026 *
110x
EV / Sales 2027 * -
Free-Float
65.56%
Yield 2026 *
-
Yield 2027 * -
1 day+2.23%
1 week-5.24%
Current month-10.09%
1 month+1.53%
3 months-9.55%
6 months-36.08%
Current year-90.84%
1 week 0.28
Extreme 0.2805
0.36
1 month 0.28
Extreme 0.2805
0.38
Current year 0.27
Extreme 0.27
1.99
1 year 0.27
Extreme 0.27
14.7
3 years 0.27
Extreme 0.27
82.16
5 years 0.27
Extreme 0.27
82.16
10 years 0.27
Extreme 0.27
117
Manager TitleAgeSince
Chief Executive Officer 50 07/09/2020
Director of Finance/CFO - 01/04/2026
Corporate Officer/Principal - 01/03/2024
Director TitleAgeSince
Director/Board Member - 26/06/2020
Chairman - 08/05/2021
Director/Board Member - 20/11/2020
Change 5-day change 1-year change 3-year change Capi.($)
+2.23%-5.24%-96.68%-98.75% 93.58L
-0.74%+3.78%+2.62%+23.10% 5.16TCr
+0.04%-1.02%+488.27%+559.44% 4.49TCr
-0.14%+7.83%+38.36%+20.71% 4.28TCr
-0.90%+2.64%+20.56%+87.09% 4.26TCr
+0.88%-3.48%+17.20%+57.20% 3.18TCr
-0.54%+3.50%+32.40%+144.45% 1.73TCr
-0.60%+1.81% - - 1.66TCr
+0.58%+4.66%+9.77%+30.87% 1.48TCr
+0.18%+3.36%+80.54%+49.17% 1.41TCr
Average +0.05%+3.53%+65.89%+97.03% 2.76TCr
Weighted average by Cap. -0.31%+5.13%+103.75%+139.97%

Financials

2026 *2027 *
Net sales 10L 1L 92.15T 86.21T 78.81T 1L 1.03Cr 2L 10.2L 4L 51.7L 4L 4L 1.71Cr -
Net income -11Cr -1.17Cr -1Cr -93.97L -85.91L -1.62Cr -112.23Cr -1.64Cr -11Cr -4.32Cr -56Cr -4.4Cr -4.31Cr -186.45Cr -6.7Cr -72.04L -61.74L -57.76L -52.81L -99.65L -69Cr -1.01Cr -6.83Cr -2.66Cr -35Cr -2.7Cr -2.65Cr -114.61Cr
Net Debt -90L -10L -8L -8L -7L -13.39L -9.27Cr -13.53L -91.81L -35.7L -4.65Cr -36.34L -35.55L -15Cr 40L 4L 4L 3L 3L 6L 4.12Cr 6L 40.8L 15.87L 2.07Cr 16.15L 15.8L 6.84Cr
Logo Lifecare ASA
Lifecare ASA is a Norway-based company that develops miniaturized and implantable nanobiosensors for correct and continuous monitoring of glucose and other biomarkers. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.
Employees
25
Date Price Change Volume
24/26/24 NOK 0.2985 +2.23% 16,15,152
21/26/21 NOK 0.2920 +1.39% 17,86,549
20/26/20 NOK 0.2880 -5.57% 21,73,636
19/26/19 NOK 0.3050 -3.79% 1,54,95,546
18/26/18 NOK 0.3170 +0.63% 13,25,809

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LIFE Stock